Manual of Clinical Psychopharmacology

by Alan F. Schatzberg, Charles DeBattista

Overview

Standard of care in psychiatry requires that practitioners stay current on new agents, interactions, side effects, and dosing guidelines -- a daunting task for the modern clinician grappling with today's challenging medical environment. The Manual of Clinical Psychopharmacology has been the psychiatrist's trusted companion for nearly three decades, and this new, eighth edition delivers the cutting-edge information clinicians need in a down-to-earth style, facilitating the integration of biological and psychopharmacological information into practice. The book's primary purpose is to provide the reader-practitioner with a practical, usable clinical guide to the selection and prescription of appropriate drug therapies for individual patients, drawing on the authors' clinical experience as well as on the scientific literature. Students of psychiatry and psychopharmacology also will find the book useful as both text and reference.

The eighth edition retains many of its most popular features, while adding others to enhance coverage and promote comprehension: • Some sections dealing with less commonly used drugs (e.g., barbiturates) have been shortened or eliminated, making space for the huge number of new agents that have been approved (e.g., vortioxetine) or are likely to receive approval from the U.S. Food and Drug Administration (FDA). This makes the volume easier to use. • The book has been thoroughly updated to reflect the release of DSM-5, which introduced dimensional measures of key dimensions (e.g., anxiety and depression) across diagnostic categories to better describe patients' disorders. In the chapter on diagnosis and classification, the authors review these major changes and the implications for prescribing.• Features of particular utility for students include the introductory chapter on the general principles of psychopharmacological treatment and the summary medication tables, which serve as quick-reference guides on classes of psychotropics.• Although largely evidence-based, the authors also draw on their extensive clinical experience in discussing various drugs' efficacy, dosing and side effects and other important factors. • Two appendixes offer suggested readings for clinicians and for patients and families, as well as information on strengths and costs of antidepressant and antipsychotic drugs. There has never been a more meticulously researched and referenced guide to prescribing psychotropic medications, nor one more down-to-earth and practical. The Manual of Clinical Psychopharmacology richly deserves its reputation as a classic in the field and has earned a place on every psychiatrist's desk.

Product Details

ISBN-13:	9781585625215
Publisher:	American Psychiatric Publishing, Incorporated
Publication date:	04/28/2015
Sold by:	Barnes & Noble
Format:	eBook
Pages:	795
File size:	2 MB
Age Range:	18 Years

About the Author

Alan F. Schatzberg, M.D., is Kenneth T. Norris, Jr., Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.

Charles DeBattista, D.M.H., M.D., is Professor of Psychiatry and Behavioral Sciences, Director of the Depression Clinic and Research Program, and Director of Medical Student Education in Psychiatry in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.

Table of Contents

PrefaceDisclosure of Competing InterestsChapter 1. General Principles of PsychopharmacologicalChapter 2. Diagnosis and ClassificationChapter 3. AntidepressantsChapter 4. Antipsychotic DrugsChapter 5. Mood StabilizersChapter 6. Antianxiety AgentsChapter 7. HypnoticsChapter 8. Stimulants and Other Fast-Acting DrugsChapter 9. Augmentation Strategies for Treatment-Resistant DisordersChapter 10. Emergency Department TreatmentChapter 11. Pharmacotherapy for Substance Use DisordersChapter 12. Pharmacotherapy in Special SituationsAppendix: Suggested ReadingsIndex

What People are Saying About This

Carl Salzman

This 8th edition, like earlier editions, is an outstanding resource for all who prescribe medications to individuals with psychiatric disorders or symptoms needing treatment. I recommend this 8th edition to all practitioners who may prescribe medications to these individuals; I also believe that this Manual will also be a useful resource for mental health clinicians who do not prescribe medications.

(M.D., Professor of Psychiatry, Harvard Medical School)

Charles B. Nemeroff

The long-awaited new edition of the Manual of Clinical Psychopharmacology fulfills all expectations...this manual becomes an essential part of every psychiatrist's practice. Succinct, yet comprehensive, it is truly a how-to of psychopharmacology...this manual should have a prominent place in every practitioner's office-not on the shelf, but on the desk.

Editorial Reviews

3 Stars from Doody

This third edition provides up-to-date information on drug therapies for psychiatric disorders to aid the clinician in making informed decisions regarding treatment selection as well as subsequent management. The authors present basic and practical information regarding psychiatric medications and provide current information regarding newer agents in a usable clinical guide. Information is derived from scientific literature and common clinical use. This is a useful manual for all practitioners of clinical psychopharmacology. In particular, it should be a valuable resource for medical students and psychiatric residents. Nurses and therapists who care for patients receiving psychotropic medications may also find it useful. An adequate number of tables and figures complement the text. References are current, but the text is sparsely referenced (as acknowledged by the authors). An extensive bibliography follows each chapter, and the appendixes include suggested reading lists for clinicians and for patients and their families. This third edition is a valuable, extremely readable resource for residents in training as well as those currently practicing psychopharmacology. Classes of psychotropic medications are reviewed, including recommendations on selection, dosing, and management of side effects. The authors will often highlight changes in treatment recommendations that have evolved since the earlier edition of 1991. Agents approved since the second edition are reviewed, such as nefazodone, venlafaxine, mirtazapine, risperidone, and olanzapine. Agents not yet approved or not approved for certain indications are also discussed, such as sertindole, quetiapine, gabapentin, andlamotragine. Chapters address varied topics: medicolegal issues, psychoeconomics, combination therapy, and special populations (pregnant women, children and adolescents, mentally retarded, geriatric , and others). This useful and practical reference replaces the earlier edition.

Katherine A. Tracy

Updates the first edition of 1986 with added sections on new drugs, expanded sections on important agents, more detailed treatment strategies for various disorders and situations, and other updates with the latest information from the literature and the authors' clinical practice. Spiral binding. Annotation c. Book News, Inc., Portland, OR (booknews.com)

Booknews

This third edition is a valuable, extremely readable resource for residents in training as well as those currently practicing psychopharmacology. Four stars
—Doody's Health Sciences Book Review Journal).

Doodys Health Sciences Book Review Journal

Reviewer: Katherine A. Tracy, MD, PhD (Rush University Medical Center)
Description: This third edition provides up-to-date information on drug therapies for psychiatric disorders to aid the clinician in making informed decisions regarding treatment selection as well as subsequent management.
Purpose: The authors present basic and practical information regarding psychiatric medications and provide current information regarding newer agents in a usable clinical guide. Information is derived from scientific literature and common clinical use.
Audience: This is a useful manual for all practitioners of clinical psychopharmacology. In particular, it should be a valuable resource for medical students and psychiatric residents. Nurses and therapists who care for patients receiving psychotropic medications may also find it useful.
Features: An adequate number of tables and figures complement the text. References are current, but the text is sparsely referenced (as acknowledged by the authors). An extensive bibliography follows each chapter, and the appendixes include suggested reading lists for clinicians and for patients and their families.
Assessment: This third edition is a valuable, extremely readable resource for residents in training as well as those currently practicing psychopharmacology. Classes of psychotropic medications are reviewed, including recommendations on selection, dosing, and management of side effects. The authors will often highlight changes in treatment recommendations that have evolved since the earlier edition of 1991. Agents approved since the second edition are reviewed, such as nefazodone, venlafaxine, mirtazapine, risperidone, and olanzapine. Agents not yet approved or not approved for certain indications are also discussed, such as sertindole, quetiapine, gabapentin, and lamotragine. Chapters address varied topics: medicolegal issues, psychoeconomics, combination therapy, and special populations (pregnant women, children and adolescents, mentally retarded, geriatric , and others). This useful and practical reference replaces the earlier edition.

Doody's Review Service